OTCMSKHHY
Market cap8.22bUSD
Dec 23, Last price
17.08USD
1D
0.29%
1Q
-6.56%
Name
Sonic Healthcare Ltd
Chart & Performance
Profile
Sonic Healthcare Limited offers medical diagnostic services in Australia. The company provides laboratory medicine/pathology; diagnostic imaging/radiology, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry; and primary care medical services comprising general practice services, occupational health services, remote health services, community and home nursing services, primary care research programs, health assessment technologies, clinical trials, and chronic disease management programs to clinicians, hospitals, community health services, and their patients. It also offers administrative services and facilities to medical practitioners. The company operates in Australia, New Zealand, the United Kingdom, the United States, Germany, Switzerland, Belgium, and Ireland. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.
IPO date
Sep 25, 1934
Employees
41,000
Domiciled in
AU
Incorporated in
AU
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | 2015‑06 | |
Income | ||||||||||
Revenues | 8,934,198 12.17% | 7,964,853 -14.42% | 9,306,543 1.96% | |||||||
Cost of revenue | 8,117,748 | 9,936,389 | 9,779,335 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 816,450 | (1,971,536) | (472,792) | |||||||
NOPBT Margin | 9.14% | |||||||||
Operating Taxes | 186,847 | 223,257 | 561,739 | |||||||
Tax Rate | 22.89% | |||||||||
NOPAT | 629,603 | (2,194,793) | (1,034,531) | |||||||
Net income | 511,094 -25.39% | 684,984 -53.10% | 1,460,566 11.07% | |||||||
Dividends | (499,413) | (480,353) | (455,397) | |||||||
Dividend yield | 3.98% | 2.86% | 2.86% | |||||||
Proceeds from repurchase of equity | 194,411 | (46,668) | (253,733) | |||||||
BB yield | -1.55% | 0.28% | 1.59% | |||||||
Debt | ||||||||||
Debt current | 661,030 | 347,204 | 341,858 | |||||||
Long-term debt | 5,381,816 | 3,833,917 | 2,670,879 | |||||||
Deferred revenue | 1,080,228 | 1,093,945 | ||||||||
Other long-term liabilities | 212,229 | 1,007,084 | 104,446 | |||||||
Net debt | 5,199,497 | 3,169,589 | 2,049,327 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 1,071,512 | 1,471,033 | 2,225,821 | |||||||
CAPEX | (470,612) | (497,013) | (378,589) | |||||||
Cash from investing activities | (1,805,443) | (580,041) | (989,180) | |||||||
Cash from financing activities | 592,406 | (911,511) | (1,349,294) | |||||||
FCF | 326,147 | (2,392,681) | (1,106,471) | |||||||
Balance | ||||||||||
Cash | 645,001 | 797,994 | 779,997 | |||||||
Long term investments | 198,348 | 213,538 | 183,413 | |||||||
Excess cash | 396,639 | 613,289 | 498,083 | |||||||
Stockholders' equity | 8,081,711 | 7,921,862 | 7,434,076 | |||||||
Invested Capital | 12,406,083 | 10,537,470 | 9,673,015 | |||||||
ROIC | 5.49% | |||||||||
ROCE | 6.20% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 476,989 | 472,444 | 482,880 | |||||||
Price | 26.30 -26.06% | 35.57 7.76% | 33.01 -14.04% | |||||||
Market cap | 12,544,798 -25.35% | 16,804,816 5.43% | 15,939,869 -13.78% | |||||||
EV | 17,901,797 | 20,159,763 | 18,144,230 | |||||||
EBITDA | 1,593,755 | (1,268,608) | 202,625 | |||||||
EV/EBITDA | 11.23 | 89.55 | ||||||||
Interest | 151,347 | 87,025 | 79,819 | |||||||
Interest/NOPBT | 18.54% |